PharmExec
JULY 10, 2023
Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.
Fierce Pharma
JULY 6, 2023
After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. | After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 7, 2023
An Epic Research study found that 16 out of 24 specialties had higher follow-up rates within 90 days of an initial office visit than a telehealth visit. This includes mental health, physical medicine and rehabilitation and pain medicine, which all had a more than 20% higher follow-up rate after an in-person office appointment than a telehealth appointment.
European Pharmaceutical Review
JULY 4, 2023
The International Organization for Standardization (ISO) has published its new standard Sterilization of health care products — Microbiological methods — Part 3 Bacterial endotoxin testing ( ISO 11737-3:2023). The document contains requirements and guidance for testing for bacterial endotoxins. This includes products that must be non-pyrogenic based on either intended use or non-pyrogenic label claim, or both.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
JULY 4, 2023
Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.
PharmaTimes
JULY 3, 2023
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Fierce Pharma
JULY 11, 2023
Caught in a litigation crossfire, Moderna has reportedly opened two new fronts in its COVID-19 vaccine patent war with Pfizer and BioNTech. | Moderna has lodged two new lawsuits at the High Court in Dublin, Ireland, and the Brussels Commercial Court in Belgium, Juve Patent first reported. This adds to a complex web of ongoing mRNA patent litigation.
MedCity News
JULY 6, 2023
Two VCs from Merck Global Health Innovation Fund recently offered fundraising advice for digital health companies. They told these firms to expect slower funding timelines, urged them not to be afraid of down or flat rounds, and advised them to spend time nailing down the specifics of their growth narrative.
European Pharmaceutical Review
JULY 3, 2023
The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. US drug product quality: drug recalls in FY2022 During the 2022 financial year, 166 manufacturing sites generated 912 drug recalls, the highest number of recalls in five years, according to the data.
Pharmaceutical Technology
JULY 3, 2023
Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Copyright Clearance Center
JULY 7, 2023
According to PW’s Andrew Albanese, the ALA conference highlighted an organized response from the library and publishing communities to politicized attacks on the freedom to read.
Pharmaceutical Commerce
JULY 11, 2023
The National Alliance of Healthcare Purchaser Coalitions releases resources for employers/health plan purchasers to offer insights on PBMs role in high prescription drug costs.
Fierce Pharma
JULY 6, 2023
Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business | Teva is looking at strategic options for its active pharmaceutical ingredient unit, with a potential sale on the table, BNN Bloomberg and Benzinga have reported.
MedCity News
JULY 5, 2023
Insurtechs like Bright Health Group, Clover Health and Oscar Health set out to disrupt health insurance — but have they actually done so? Not in a positive way, several experts say.
European Pharmaceutical Review
JULY 7, 2023
New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.
PM360
JULY 26, 2023
As biosimilars make inroads across various disease states, oncology especially appears to have embraced the new breed of therapies. Biosimilar adoption, however, is not as simple as picking the lowest-cost option, according to one expert. Deciding which biosimilars to use requires a complex set of considerations for oncology clinics, notes Andre Harvin, PharmD, Executive Director of Pharmacy and Oncology Services at Cone Health.
Copyright Clearance Center
JULY 19, 2023
Together, this panel reflected on successful collaborations that streamline OA processes, remove unnecessary work for the researchers, and enable cross-stakeholder transparency.
Spotio
JULY 25, 2023
B2B sales has evolved over the years. Cold calling and direct mail are still useful for some sales processes, but the way in which we do business has changed a lot. More companies are investing in B2B sales teams — inside and outside — across a range of industries. The B2B buying process now has more decision-makers and touchpoints than it did just a few years ago.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Fierce Pharma
JULY 10, 2023
Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbust | Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbuster products.
MedCity News
JULY 5, 2023
Butterfly Network recently launched an AI tool that can provide medical practitioners with an accurate B-line count from just a six-second lung ultrasound clip. By automatically counting B-lines in a lung image, the tool helps doctors quickly identify and assess a patient’s lung issues at the point of care.
European Pharmaceutical Review
JULY 31, 2023
The first treatment for children and adolescents who have epileptic seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) has been approved in the EU by the European Commission (EC). EC has granted approval of ZTALMY ® (ganaxolone) oral suspension as adjunctive treatment in CDD patients from two to 17 years old. The European regulatory body’s decision “represents a significant milestone” according to Dr Scott Braunstein, Chairman and Chief Executive Off
PM360
JULY 26, 2023
Today, the U.S. is facing an aging population, a mounting physician shortage, and increasing demands for a more equitable healthcare system. 1 According to the U.S. Surgeon General, burnout among healthcare workers has reached crisis levels. 2 It’s no wonder physicians across the country are limiting time with the industry and prioritizing their limited time with their patients.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Pharma Marketing Network
JULY 25, 2023
In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.
PharmExec
JULY 31, 2023
Rebekah Martin, senior VP of reward, inclusion, and talent acquisition at AstraZeneca, discusses ways to address the need for talent in pharma, how pharma can increase more interest in young talent, and how many roles in pharma will require a degree in the coming years in this Pharmaceutical Executive Podcast video.
Fierce Pharma
JULY 7, 2023
As demand skyrockets for GLP-1 drugs that can trigger significant weight loss, unauthorized versions of the treatments have started to fill pharmacies. | In late May, the FDA warned of illegal knockoffs of Novo Nordisk’s Ozempic and Wegovy. And now, the Danish company has filed its second wave of lawsuits against pharmacies in the U.S. that are producing the copycats.
MedCity News
JULY 5, 2023
Providers often have a checklist of requirements they use to determine whether they should bring new technology into their organization. Digital health startups would be wise to learn about these criteria when taking their products to market, said Meg Barron, the AMA’s vice president of digital health strategy, at a recent conference. That way, startups can build their products around meeting providers’ needs.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
European Pharmaceutical Review
JULY 28, 2023
A research paper has reported a practical framework suitable for a systematic step-by-step quality by design (QbD) approach for the pharmaceutical development of bilayer tablets. According to the authors, bilayer tablets have been considered one of the best options for the development of fixed-dose combination (FDC) formulations. By delivering active substances, they can avoid incompatibilities in solubility, stability, and therapeutic efficacy in a single dosage form.
PM360
JULY 26, 2023
Digital fireworks were launched just hours after the July 4 th holiday in the U.S. with the official launch of Threads by Meta, a new platform that is a direct competitor of Twitter. It should be of no surprise to anyone that a flurry of Twitter competitors is now entering the marketplace. Ever since Elon Musk’s purchase of Twitter, a target has been on the back of one of the original and most polarizing social platforms.
Copyright Clearance Center
JULY 18, 2023
July 18, 2023 – Danvers, Mass. – CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC). Earlier this year, CCC engaged with members of the ESAC Initiative and administrators at university libraries representing nine global consortia across the U.S. and Europe to
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Expert insights. Personalized for you.
119 
Let's personalize your content